Serum Endocan Levels in Children with Febrile Neutropenia.

Creative Commons License

Kiral E., DİNLEYİCİ E. Ç., Bozkurt-Turhan A., BÖR Ö., Akgun Y., Akgun N. A.

Hematology reports, vol.8, no.1, pp.6110, 2016 (Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.4081/hr.2016.6110
  • Journal Name: Hematology reports
  • Journal Indexes: Scopus
  • Page Numbers: pp.6110
  • Keywords: Leukemia, acute lymphoblastic leukemia, children, endocan, febrile neutropenia, CELL-SPECIFIC MOLECULE-1, MARKER, SEVERITY, SURVIVAL, TARGET
  • Eskisehir Osmangazi University Affiliated: Yes


Endocan is an endotelial cell specific molecule; previous studies have shown that serum endocan levels increased in cancer and sepsis and are also related to the severity of sepsis. There are no clinical study about serum endocan levels in children with febrile neutropenia. The aim of this study was to evaluate serum endocan levels in pediatric leukemia patients with febrile neutropenia (n=33) and compare them with children with leukemia without fever (n=33) and also with healthy children (n=24). The median serum endocan level in the first group (children with febrile neutropenia) was statistically significantly higher compared to the leukemic children without febrile neutropenia and also control group (P<0.01 for both). No difference was determined between the serum endocan levels of the leukaemia patients without febrile neutropenia and the healthy control group (P>0.05). Serum endocan levels were also similar with febrile neutropenia due to bacterial causes comparing with the idiopathic febril neutropenia. The results of this study showed increased serum endocan in children with leukemia during the febrile neutropenia episode, and no changes of serum endocan levels in children without leukemia without infection/fever. The monitoring of a series of serum endocan levels would be helpful for the course of febrile neutropenia.